2019 OHSU Commercialization Conference

 2019 Commercialization Conference banner

The 2019 Commercialization Conference connects OHSU innovators with investors, industry partners and community collaborators to help build a vibrant regional hub for innovative technology. Speaker sessions, startup pitches, industry insights and collaboration stories will focus on the theme of Fueling Health Care Innovation. The conference offers a platform for attendees to explore the impact of and understand the drivers of innovation that will revolutionize health care. 

OHSU Technology Transfer and Business Development celebrates the sixth year of our signature conference, formerly the Startup Symposium, by expanding the framework to include startup and established enterprises. Take advantage of the networking sessions, presentations highlighting industry and academic trends and breakout sessions offering professional development at this year's OHSU Commercialization Conference.


Fireside Chat keynote

Ken Fisher
Founder, executive chairman and co-chief investment officer, Fisher Investments

Ken FisherKen Fisher is the founder, Executive Chairman and Co-Chief Investment Officer of Fisher Investments, a multi-billion dollar money management firm serving large institutions and high net worth individuals globally. His four best-selling books, as well as columns and commentary in USA Today and The Financial Times, provide a unique and original point of view on investing and retirement planning.




Opening keynote

Jared L. Short
Chief operating officer, Cambia Health Solutions

Jared L. ShortJared Short leads the accelerated pace of innovation and performance across the Cambia organization to ensure consumer focused solutions. As chief operating officer, Mr. Short  leverages his commitment and insight into consumer needs to execute against the company’s Cause of transforming health care to be person focused and economically sustainable. 

Mr. Short also fills the role of president of Cambia’s Health Insurance Services division, which serves 2.4 million members covered by seven health plans in Idaho, Oregon, Utah and Washington. He successfully drives award-winning service, facilitates collaborative partnerships between providers and patients, and helps create innovative new solutions meeting the needs of a rapidly changing marketplace.

Mr. Short's career with Cambia began in 1999, when he joined the company in a Finance role with cross-functional responsibilities across the organization.  He moved briefly to BlueCross BlueShield of Montana, where he served as chief marketing and underwriting officer. Mr. Short returned to Cambia in 2009 as president of Cambia’s regional health plan in Oregon, responsible for sales, provider contracting, and government and community relations. 

Mr. Short serves on the Board of Directors for TriWest Healthcare Alliance and GNS Healthcare. He also serves on the Board of Directors for the Portland Metropolitan Area Boys and Girls Clubs.

He received his Bachelor of Science degree in economics and history from Willamette University in Salem, Oregon.


Afternoon keynote

Neal Sandy, M.B.A.
Chief marketing and commercial officer, Clinical Support Solutions, GE Healthcare

Neal SandyNeal Sandy leads global marketing and strategy for the Clinical Support Solutions segments of GE Healthcare. He is responsible for Strategy, Marketing, Business Development and Commercial Excellence for the segments which includes the product lines of Ultrasound, Monitoring, Anesthesia, Respiratory, Diagnostic Cardiology and Maternal and Infant Care.

Mr. Sandy has been with GE for thirteen years in several executive product management and marketing roles including his most recent assignment as Chief Marketing Officer at GE Ventures. His healthcare background includes roles in the medical devices, IT and pharmaceutical industries. Mr. Sandy gained his entrepreneurial experience as COO of an oncology pharmaceutical company called Cellectar Biosciences. He brings extensive international experience in strategic marketing, commercial marketing, business management, business development and product management.

Mr. Sandy holds a Bachelor's degree in Business Administration from St. Norbert College in De Pere, Wisconsin and a M.B.A. in Marketing from the University of Wisconsin in Madison. He is married with three children and is based in Madison, Wisconsin.




Eric D. Agdeppa, Ph.D., MTM
Executive director of innovation and general manager, Hill-Rom

Agdeppa, EricEric Agdeppa has focused on molecular imaging of a variety of diseases and other modalities for sensing critical patient parameters for early and effective care, aiming to transform healthcare through research, development, and commercialization of cutting-edge products and technology. Since 1996, his industrial career includes research, development, product management, business development, and front-end innovation at Hill-Rom, GE Healthcare, GE Global Research, and North American Scientific.

Since 2011 Dr. Agdeppa leads Hill-Rom's efforts to develop new, game-changing technologies through internal development efforts and relationships with academic and strategic corporate partners. As the Executive Director of Innovation and part of Hill-Rom's R&D Leadership Team, he leads two innovation groups (the Early Innovation and Global Technology Integration organizations) and one data science team that accelerate the company's innovation efforts and drive value-added technologies into future health care products. Dr. Agdeppa is also the General Manager of Hill-Rom's first incubated, intrapreneurial startup within Hill-Rom. Nurturing the broader ecosystem of health care innovation and STEM, Dr. Agdeppa recently served on the Board of Directors for Alberta Innovates –Health Solutions (AIHS). As an internationally recognized catalyst for change in healthcare, AIHS is made up of national and international research and business leaders whose guidance of the corporation's strategy and directions in health research and innovation activity yields improved health and well-being for Albertans. He still nurtures future scientists and engineers through his local involvement of a secondary school STEM program and advising master and doctoral students at UCLA.  Dr. Agdeppa received his B.S. in Biochemistry from UCLA, his Masters in Technology Management from Stevens Institute of Technology, and his Ph.D. in Biomedical Physics with a specialization in Biophysics/Nuclear Medicine also at UCLA.

Rob Arnold
Entrepreneur-in-residence, OHSU

Rob ArnoldRob Arnold is a Founding Member of HealthCommonsProject.org and CEO of Quad Aim Partners, operator of the Commons IT Network. HealthCommonsProject.org helps communities organize, coordinate and get paid to deliver personalized care to the most vulnerable—the 5% of the population that consumes 50% of all healthcare costs. In addition to the Commons, Mr. Arnold is an Executive in Residence at University of Washington, OHSU and Fred Hutch. Previously, Mr. Arnold was a strategic advisor to Clario Medical (sold to Intelerad), CEO of Geospiza (sold to Perkin Elmer), CEO of Crossport Systems (sold to Metroworks/Motorola) and STLabs (sold to Lionbridge).


Imran Babar, Ph.D.
Chief business officer, Cydan II Inc.

Imran BabarImran Babar is Chief Business Officer of Cydan, which is a venture-backed orphan drug accelerator. Dr. Babar comes to Cydan from the venture capital team at OrbiMed Advisors. While at OrbiMed, Dr. Babar was involved with a wide range of companies, mostly in the therapeutics space. Prior to joining OrbiMed, Dr. Babar was on the equity research team at Cowen where he covered over 20 biotechnology companies. He is also Co-founder of Rare Genomics Institute (RG), a nonprofit dedicated to helping rare disease patients since 2011. Under his leadership, RG has implemented numerous initiatives to accelerate research for rare diseases. Imran completed his Ph.D. in Molecular Biology at Yale University and his B.A. in Biology at Carleton College. 


Susan Bakewell-Sachs, Ph.D., R.N., F.A.A.N.
Vice president for Nursing Affairs and Professor and dean, School of Nursing, OHSU

Susan Bakewell-SachsSusan Bakewell-Sachs is Vice President for Nursing Affairs, Professor, and Dean at OHSU School of Nursing. Dr. Bakewell-Sachs has a clinical background as a pediatric nurse practitioner and is a nationally recognized scholar and clinical expert in the primary care of medically fragile children, born prematurely. She is also a recognized expert in nursing education, interprofessional education, and academic-practice partnerships, seeking ways to develop and evaluate innovative models of education and practice to prepare health care professionals and improve patient care.

Dr. Bakewell-Sachs was a Robert Wood Johnson Foundation (RWJF) Executive Nurse Fellow, Cohort 2007 and also served as the Program Director for the New Jersey Nursing Initiative, an RWJF program aimed at addressing the nurse faculty shortage through new curriculum models, faculty development, and academic-practice partnerships. Dr. Bakewell-Sachs is currently serving as a member of the Board of Directors of the American Association of Colleges of Nursing and of the Oregon Action Coalition Steering Committee. Dr. Bakewell-Sachs is a fellow in the American Academy of Nursing.


Abhijit Banerjee, Ph.D., M.B.A.
Senior director, Business Development, OHSU

Abhijit BanerjeeAbhijit Banerjee oversees the Business Development function at OHSU as an interface between OHSU investigators and the pharmaceutical/biotech industry, helping develop strategic alliances with industry, foundations, and government. Dr. Banerjee is also responsible for supporting OHSU's startup companies and participates in strategic initiatives related to commercialization of OHSU's assets and technologies. Recently he was invited to join the GE Ventures Advisory Council.

Prior to joining OHSU, Dr. Banerjee was a Senior Consultant with Deloitte and a Strategic Alliance Manager at Pfizer. He has worked as a researcher at Imperial College in London and at Boston University. Dr. Banerjee received his Ph.D. from the India Institute of Chemical Biology in India and his M.B.A. from Suffolk University in Boston, completing his post-doctoral training at the University of Wisconsin-Madison. 


Peter G. Barr-Gillespie, Ph.D.
Chief research officer and executive vice president, OHSU

Peter Barr-GillespiePeter Barr-Gillespie is a professor in the department of otolaryngology, an affiliated scientist with the Vollum Institute, and the chief research officer and executive vice president for OHSU. He is also the scientific director of the Hearing Restoration Project, funded by the Hearing Health Foundation. Dr. Barr-Gillespie oversees the research mission at OHSU, which includes the entire spectrum of science, from molecules to populations. His role is to provide research infrastructure and support, from fiscal management to shared instrumentation to long-term strategy. He also oversees nine of OHSU's research centers and institutes. Dr. Barr-Gillespie has an active, well-funded basic science research program, the goal of which is to understand how the sensory cells of the inner ear, hair cells, detect mechanical signals like sound and head movements.


Dylan Boyd
Director, R/GA Ventures

Dylan BoydDylan Boyd loves working with early growth companies. He has worked with hundreds of founders and invested in over 200 companies.

Mr. Boyd is currently the Director, New Program Development of R/GA Ventures where he works with global brands to develop in house, partner, and studio programs. R/GA is a global digital agency that creates early stage products, digital services, and experiences. Mr. Boyd led the growth and launches of the Techstars vertical accelerator programs for Sprint (Mobile Health), R/GA(Connected Devices/IoT), Barclays (FinTech), Nike (Digital Health and Sport), Disney (Entertainment and Content), among others.

In Mr. Boyd's past lives, he built startup companies, global e-commerce initiatives, online business solutions for large corporations/major brands with integrated interactive content, and strategy programs. He has been fortunate enough to be honored with creative and business awards, including three INC 500/5000 awards.


Wellesley Chapman, M.D.
Medical director of innovation and business development, Kaiser Permanente of Washington

Wellesley ChapmanWellesley Chapman is Medical Director of Innovation & Business Development at Kaiser Permanente of Washington (KPWA). He joined KPWA (then Group Health) in 2008, serving as a Primary Care physician, Medical Center Chief, and Lean consultant prior to founding the Innovation team in 2013 with business partner, Elizabeth Fleming. Dr. Chapman has a B.A. in Economics from the University of Vermont and an M.D. from the University of Washington. Prior to his work in healthcare, Dr. Chapman was a theater actor in Chicago, a financial analyst in New York and Paris, and a Kerouac-wannabe-expat-bartender-lay-about.



Alice Chen, Ph.D.
Vice president, Accelerator Life Science Partners

Alice ChenAlice Chen is the vice president of Accelerator Life Science Partners, an investment and development firm for early-stage life science technologies. Since its inception, Accelerator has created 20 biotechnology companies with top-tier venture and strategic investors. Dr. Chen has played an instrumental role in the sourcing, evaluation, formation, oversight, and partnership initiatives of several Accelerator portfolio companies. Dr. Chen holds a Ph.D. in Chemical Engineering from Stanford University. She served as an Engineering Fellow at Merck & Company and is currently serving on the Evergreen Fund Advisory Committee for Fred Hutch Cancer Research Center and the board of Life Science Washington, the state's life science trade association.


Travis G. Cook, M.S., M.B.A., CLP
Senior technology development manager, Technology Transfer and Business Development, OHSU

Cook, TravisTravis Cook is a cross-functional international business development professional with experience in managing, negotiating, and closing early-, late-, and commercial-stage definitive agreements. He is a co-inventor on seven patent applications and is a co-author of several peer-reviewed publications, including a case study in the management textbook, Building a Case for Biotechnology.

Mr. Cook was previously the Director of Business Development at Galena Biopharma, Inc. (Nasdaq: GALE) and has held appointments at OHSU, Kalypsys, Inc., Ansata Therapeutics, Inc., and Mixture Sciences, Inc. He received a M.S. in chemistry from UC San Diego, and a M.B.A. from Willamette University. 

Mr. Cook is passionate about spending time with his family and recreating in the outdoors where he can be found whitewater kayaking, rock climbing, mountain biking, surfing, and skiing.


Ray Costantini, M.D., M.B.A.
Co-founder and chief executive officer, Bright.md

Ray ConstantiniRay Costantini is a pioneering healthcare business leader, innovative physician, and seasoned entrepreneur who is passionate about healthcare. Prior to founding Bright.md, he led the design, build, deployment, and operations of three groundbreaking telehealth and digital health products at one of the largest health systems in the country. He also previously founded three successful companies, and is a national speaker on healthcare innovation, telehealth, and patient engagement. Dr. Costantini earned his M.D. and B.S. degrees from the University of Arizona, where he was Phi Beta Kappa and Magna Cum Laude, and, his M.B.A. from the Thunderbird School of Global Management.



Kanad Das, Ph.D.
Investment director, Boehringer Ingelheim Venture Fund

Kanad DasKanad Das joined the Boehringer Ingelheim Venture Fund from Merck (MSD) where he was Director, Business Development and Licensing in their West Coast Innovation Hub. He led efforts in Immuno-Oncology, Cardiovascular and Metabolic Diseases and Ophthalmology in the preclinical space up to human proof of concept. Dr. Das started his career at Genentech as a post-doctoral fellow, then going to KAI Pharmaceuticals as a medicinal chemist. There he was an inventor of Parsabiv, approved in 2017 for the treatment of Secondary Hyperparathyroidism. After KAI, Dr. Das worked at Stanford University’s SPARK program, an academic accelerator designed to take basic science discoveries and bring them to fundable assets. He Received his Ph.D. in Chemistry from the University of Massachusetts, Amherst and a B.Sc. in Chemistry from UC Berkeley.


Jeffrey W. Gaus
Founder, Oregon Blockchain Venture Studio

Jeff GausJeff Gaus is the Founder of the Oregon Blockchain Venture Studio (OBVS), which intends to establish Oregon's prominence in this emerging technology. Additionally, Mr. Gaus serves as the Board Chair for Young Entrepreneurs Business Week (YEBW) whose mission is to educate and inspire the next generation of business leaders.

Mr. Gaus is a seasoned technology executive having served as the CEO of Prolifiq Software, VP Marketing for eFusion, and Executive Director Healthcare, Education and Government for NEC.

Mr. Gaus completed his education at Indiana University of Pennsylvania in Marketing and post-graduate work at Carnegie Mellon University's Tepper School of Business.


Charlotte Hubbert, Ph.D.
Partner, Gates Foundation Venture Capital

Charlotte HubbertCharlotte Hubbert is a Partner with Gates Foundation Venture Capital and oversees investing in innovative technologies that support the foundation's programs in global health and agriculture. She currently serves on the BODs of Sera Prognostics, Lodo Therapeutics, Vir Biotechnology and Vedanta Biosciences. Dr. Hubbert was previously Vice President at H.I.G. BioVentures investing broadly in healthcare and began her career at Accelerator Life Science Partners as founding management of five companies. Dr. Hubbert holds a Ph.D. from Duke University and is a Kauffman Fellow. She was named a Fierce Woman in Biopharma 2016 and a leading Woman in Life Sciences 2016 by LSW.


John Hunter, M.D., FACS, FRCS Edin (honorary)
Executive vice president, OHSU and Chief executive officer, OHSU Health System

John HunterJohn Hunter attended Harvard College, where he graduated with a degree in English Literature, and then attended medical school at the University of Pennsylvania. His surgical residency took place at the University of Utah, and he did fellowships in surgical endoscopy at the Massachusetts General Hospital and the University of Western Ontario. Following his fellowships, Dr. Hunter returned to Utah in 1988 to start the surgical endoscopy and minimally invasive surgery program at the University. In 1992, he relocated to Emory University in Atlanta, where he served as Chief of GI surgery and Vice Chair of Surgery (clinical). Nine years later, in 2001, Dr. Hunter traveled to OHSU to become the Mackenzie Chair of Surgery and Surgeon in Chief of the OHSU health system. He was the Interim Dean of the OHSU School of Medicine in 2016-17, the Chief Clinical Officer and Chair of the OHSU Practice Plan. He now serves as the Executive Vice President and Chief Executive Officer of the OHSU Health System. 


Danny Jacobs, M.D., M.P.H., F.A.C.S.
President, OHSU

Jacobs, DannyDanny Jacobs was born in Camden, Arkansas. After graduating from Harvard College, he received his medical degree from Washington University in St. Louis and completed general surgery clinical and research training at the University of Pennsylvania at the Brigham and Women’s Hospital in Boston. An acclaimed surgeon-scientist, Dr. Jacobs has held senior leadership positions at a number of leading academic medical centers having most recently served as chief academic officer for the University of Texas Medical Branch in Galveston, Texas.  



Luis Machuca, M.S.I.E.
Chief executive officer, Enli Health Intelligence

Luis MachucaLuis Machuca is the Chief Executive Officer of Enli Health Intelligence, the market leader in population health technology.

Mr. Machuca received his B.S.E.E. in 1980 and a M.S.I.E. in 1981, both from Purdue University. He joined Intel Corp. in 1981 and spent 15 years in a variety of executive management roles before becoming General Manager of Intel's OEM Products and Services Division. In 1996, Mr. Machuca became an Executive Vice President at NEC Computer Services, a division of PB-NEC Corp. In 1999, he joined eFusion Corp. as President and Chief Operating Officer, and subsequently helped steer the company through a merger with ITXC. In addition to his role at Enli, he serves on the board of directors of Cambia Health Solutions and Umpqua Bank and Echo Health Ventures.


Michael Main, M.B.A.
Managing director, Monitor Deloitte

Main, MichaelMichael Main is a Managing Director in Monitor Deloitte's Healthcare Strategy practice. His leadership across corporate strategy, growth and architecting the health plan and health system of the future is founded in deep industry expertise. Mr. Main's experience spans Plans, Providers, Integrated Delivery Systems, ACO's, and Specialty companies. Mr. Main has supported client companies' CEOs, board of directors, executive teams, and functional leadership to enable new care model innovation

Mr. Main holds a M.B.A. from the Kellogg Graduate School of Management at Northwestern University and a B.S. from Kent State University. 


Kuldeep Neote, Ph.D.
Senior director, New Ventures, J&J Innovation Center

Kuldeep NeoteKuldeep Neote is senior director at J&J Innovation Center-Boston and is responsible for New Venture activities for the Janssen R&D in the East Coast. He has been responsible for several academic and biotech collaboration including two opportunities in Canada and served as the interim Head of JLABS@Canada.

Dr. Neote is trained as a Molecule Biologist with an extensive background in drug discovery. He has been focused in the area of Immunology, Inflammation and Oncology and has a passion for implementing cutting edge scientific discoveries into practical drug discovery programs. Throughout his career, he has looked at creative scientific and business development collaborative and partnering opportunities that have resulted in tangible clinical translation of new scientific discoveries working in conjunction with academic and biotech companies.

Formerly, Dr. Neote was Research Advisor/Director in Global External R&D at Eli Lilly in Indianapolis, IN and responsible for search and evaluation of Oncology in-licensing opportunities. Prior to Eli Lilly, he was a Discovery Scientist in Pfizer Inc. in Groton, CT. Dr. Neote initiated the Chemokine Receptor Drug Discovery platform that lead to several clinical candidates, and also discovered novel chemokines. Earlier in his career, Dr. Neote cloned one of the first chemokine receptors during his post-doctoral studies in Genentech.

Dr. Neote earned his BSc. in Microbial and Cellular Biology at the University of Calgary, Calgary, Canada, and a Ph.D. in Human and Molecule Genetics at the University of Toronto, Toronto, Canada, where he was a major contributor in the understanding of the molecular basis of lysosomal storage diseases, in particular Tay Sachs and Sandhoff’s disease.


Samantha O'Connor, B.Sc.(Hons), M.B.A.
Executive director and head of operations and portfolio management, Pfizer's Centers for Therapeutic Innovation

Sam O'ConnorSam O'Connor leads the operations and portfolio management activities for Pfizer's Centers for Therapeutic Innovation (CTI), a pioneering model designed to bridge the gap between early scientific discovery and its translation into new medicines. In this role, Ms. O'Connor has responsibility for defining and implementing the evolving business strategy, operational processes and alliance management practices required to drive success of this novel partnering model. In an industrial career spanning more than two decades, Ms. O'Connor has extensive business development and alliance management experience across Europe, Australasia and the USA, collaborating with a diverse range of parties including academia, biotechnology and pharmaceutical companies, patient-focused foundations, investors and policy makers.


Ketan Paranjpe, M.B.A., M.S.
Vice president, Diagnostic Information Solutions, Roche

Ketan ParanjpeKetan Paranjpe is the VP of Diagnostics Information Solutions at Roche and his team focuses on harnessing the power of data, diagnostics and other critical information to support better clinical decisions. Prior to this role he was a Managing Director at Health2047 and General Manager of Life Sciences at Intel Corp. He has been a member of the US Health IT committee on Precision Medicine, and part of numerous taskforces at AAAS-FBI-UNICRI, ITU and WHO.

Mr. Paranjpe holds M.S. degrees in Electrical Engineering and Computer Sciences from the University of Wisconsin and an M.B.A. from the University of Oregon, where he was the class valedictorian. He also completed the Stanford Executive Program as well as coursework in Healthcare Management at the Harvard School of Public Health. He is an Honorary Research Fellow at the Imperial College London and Technical Advisor in Artificial Intelligence at Lee Kong Chian School of Medicine Singapore. Ketan is a certified Paramedic and resides in Indianapolis with his wife and son. 


Brigitte Piniewski, M.D.
Strategic advisor, Healthcare at NexCubed

Brigitte PiniewskiBrigitte Piniewski is a physician, author, researcher and blockchain enthusiast. After years as a primary care physician with obstetrics, she moved into medical administration as Chief Medical Officer for PeaceHealth Labs. In this role, Dr. Piniewski built strategic alliances with multiple academic centers including the University of Oregon, Continua Health Alliance and various health technology providers to advance population health. More recently, she has been delivering in person and web-based instruction for investors covering Blockchain technology. Dr. Piniewski graduated in Medicine from the University of British Columbia and completed her internship at McGill University Canada. She resides in Portland, Oregon. 


John Sabol, Ph.D., MSc.
Chief scientist, GE Healthcare's Global Research Organization

John SabolJohn Sabol is the Chief Scientist for GE Healthcare's Global Research Organization. He is responsible for the scientific oversight of strategic research collaborations and clinical trials for global regulatory submissions. Before concentrating on clinical research and academic partnerships, he led the invention and development of new medical imaging concepts, algorithms, and applications from the laboratory through prototype development and clinical implementation. Dr. Sabol holds a BSc. in Physics and Philosophy, and MSc. and Ph.D. in Medical Physics from the University of Toronto. He has published 36 articles in peer reviewed journals, given over 65 conference presentations including invited and plenary talks, and has 57 issued U.S. and international patents. Personally, he enjoys mentoring youth in STEM activities and Boy Scouts. When not mentoring, or spending time with his wife and three children, Dr. Sabol pursues his true passion, fly-fishing.


Kurt Sheline, M.B.A.
Principal, Strategic Investments, Echo Health Ventures

Sheline, KurtKurt Sheline is a Principal on the Strategic Investment Team at Echo Health Ventures, where he is involved in all aspects of the investment and portfolio management process, and has supported Echo's investments in GNS Healthcare, Octave Bioscience, Circulation, Phreesia, AccessOne, and Springbuk. Before joining Echo in 2017, Mr. Sheline was a Vice President in Cascadia Capital's Healthcare Technology and Services group, based in Seattle, where he worked closely with management teams in the life sciences, healthcare technology, and health care services industries, providing business development, positioning, sales and marketing, and transaction advisory and execution services. Mr. Sheline earned an M.B.A. from the University of California, Berkeley,and a bachelor's degree, magna cum laude, in Economics/Pre-Medical Studies from Claremont McKenna College.


Sreenivas Rangan Sukumar, Ph.D.
Senior analytics architect, Office of the CTO, Cray Inc.

Sreenivas Rangan SukumarSreenivas "Rangan" Sukumar is an artificial intelligence researcher, a data scientist and a serial-entrepreneur that thrives on (i) impactful (ii) creative and (iii) challenging opportunities to bridge technology, business and people towards "remarkable" products. His expertise from working at Cray Inc. and previously at the Oak Ridge National laboratory is in architecting intelligence augmentation solutions for scientific and enterprise Big Data discovery - particularly with workflows that handle complex data modalities such as genomes, sensors, knowledge graphs, images, free-text, tabular/transactional records. Dr. Sukumar's work has contributed to (i) better government policy decisions towards making healthcare affordable, (ii) solving mystery illnesses and (iii) commercialization of the workflows to accelerate diagnosis and drug-discovery via health-innovation startups such as ConceptualEyes and In-Depth Genomics.


Andrew R.O. Watson, Ph.D., CLP
Senior director, Technology Transfer, OHSU

Andrew WatsonAndrew Watson manages the licensing, commercialization, intellectual property protection, and industry collaborations aspects for OHSU's Technology Transfer and Business Development office. He is involved in the day-to-day management of the office and technology transfer staff as well as having significant input into preparation and management of departmental budgets. He is also involved in developing and implementing university policies, providing leadership in developing strategies for corporate collaboration, advising on IP contract provisions, actively negotiating complex business agreements, and serving as an OHSU spokesperson for matters relating to IP, commercialization and economic impact of OHSU research. He has authored several scientific publications and technology transfer articles, and also has been an invited speaker at both scientific and technology transfer conferences. Dr. Watson received his B.S. from Whitworth University and his Ph.D. in Biomedical sciences with a research emphasis in immunology and infectious diseases from the State University of New York.


Leon Wolf, M.S.
SBIR/STTR assistance manager, VertueLab

Leon WolfLeon Wolf is the SBIR/STTR Assistance Manager at VertueLab in Oregon. This assistance program and the conference workshop are partly funded by the US Small Business Administration. Mr. Wolf is also the principal at Leon Wolf Consulting LLC which provides private grant writing support, and he has been helping companies get SBIR/STTR funding since 2013. Mr. Wolf has an M.S. in Chemical Engineering and 35 years professional experience in industry and the entrepreneurial ecosystem.  

Schedule of events

Wednesday, March 27, 2019

12:30 - 3:30 p.m.

SBIR/STTR workshop
* Separate registration required to attend; Registration for this add-on workshop has hit capacity.

Leon Wolf, M.S.
SBIR/STTR assistance manager, VertueLab
3 - 4 p.m.
Check In 
4:00 - 4:20 p.m.
Opening remarks

Abhijit Banerjee, Ph.D., M.B.A.
Senior director, Business Development, OHSU

John G. Hunter, M.D., F.A.C.S.
Executive vice president, OHSU and chief executive officer, OHSU Health System
4:20 - 5 p.m.
Fireside chat: A generalist global investor's views on the future of Healthcare investments
Ken Fisher
Founder, executive chairman and co-chief investment officer, Fisher Investments
5 - 6:10 p.m.
Propelling innovation within incubators and accelerators

Jeff Gaus
Founder, Oregon Blockchain Venture Studios

Dylan Boyd
Director, New Programs Development, R/GA Ventures

Alice Chen, Ph.D.
Vice president, Accelerator Life Science Partners

Kanad Das, Ph.D.
Investment director, Boehringer Ingelheim Venture Fund

6:10 - 8:30 p.m.

Opening reception

Enjoy an evening of reacquainting with old friends, making new connections, northwest inspired hors d'oeuvres and refreshments, and live musical entertainment.



Thursday, March 28, 2019

7:30 - 8:30 a.m.
Check in and continental breakfast
8:30 - 9 a.m.
Opening remarks

Abhijit Banerjee, Ph.D., M.B.A.
Senior director, Business Development, OHSU

Peter Barr-Gillespie, Ph.D.
Chief research officer and executive vice president, OHSU

Danny Jacobs, M.D., M.P.H., F.AC.S.
President, OHSU

9 - 9:45 a.m.
Opening keynote: Humanizing data and technology for personalized health care experiences
Jared L. Short
Chief operating officer, Cambia Health Solutions
9:45 - 11 a.m.
Executive panel: Drivers of the future health care system in the U.S.

Abhijit Banerjee, Ph.D., M.B.A. - moderator
Senior director, Business Development, OHSU

Susan Bakewell-Sachs, Ph.D., R.N., F.A.A.N.
Vice president, Nursing Affairs and professor and dean, OHSU School of Nursing

Wellesley Chapman, M.D.
Medical director of innovation and business development, Kaiser Permanente Washington

Luis Machuca, M.S.I.E.
Chief executive officer, Enli Health Intelligence

Michael Main, M.B.A.
Managing director, Monitor Deloitte

11 - 11:15 a.m.
Networking break 
11:15 - 12:30 p.m.
Company pitches

Christina Lorentz, Ph.D.
Director of clinical research, Aronora, Inc.

Frank Oliver
Chief technology officer, Data Dome, Inc.

Duffy DuFresne, M.B.A.
Chief executive officer, OmnEcoil Instruments, Inc.

Theodore Hobbs, D.V.M., M.C.R.
Founder, Quantiport, Inc.

Anna Brown, Ph.D.
Chief executive officer and founder, Stark Street Materials Corporation

12:30 - 2 p.m.

Lunch and poster session

2 - 2:05 p.m.
Afternoon keynote introductionAndrew R.O. Watson, Ph.D., CLP
Senior director, Technology Transfer, OHSU
2:05 - 2:45 p.m.
Afternoon keynote: Patient care delivery in a maturing digital world
Neal Sandy, M.B.A.
Chief marketing and commercial officer, Clinical Support Solutions, GE Healthcare
2:45 - 3:05 p.m.
Networking break
3:05 - 4:20 p.m.
Breakout sessions

Session 1: Breaking through health care's innovation indigestion with next generation IT

Rob Arnold - moderator
Entrepreneur-in-residence, OHSU

Ray Constantini, M.D., M.B.A.
Chief executive officer and co-founder, Bright.MD

Brigitte Piniewski, M.D.
Strategic advisor, Healthcare at Nex Cubed

Kurt Sheline, M.B.A.
Principal, Strategic Investment, Echo Health Ventures

Sreenivas Rangan Sukumar, Ph.D.
Senior analytics architect, Office of the CTO, Cray Inc.




Session 2: Moving health care innovation through academic-industry partnerships

Eric Agdeppa, Ph.D. - moderator
Executive director of innovation and general manager, Hill-Rom

Sam O'Connor, M.B.A.
Executive director and head, Strategy and Business Planning, Centers for Therapeutic Innovation, Pfizer

Ketan Paranjape, M.B.A., M.S.
Vice president, Diagnostics Information Solutions, Roche

John Sabol, Ph.D., MSc.
Chief scientist, Global Research Organization, GE Healthcare

 Session 3: Risks that VCs and Corporate VCs take in funding early innovation: Sharing some success stories

Travis G. Cook, M.S., M.B.A., CLP - moderator
Senior technology development manager, Technology Transfer and Business Development, OHSU

Imran Babar, Ph.D.
Chief business officer, Cydan Development, Inc.

Charlotte Hubbert, Ph.D.
Partner, Gates Foundation Venture Capital

Kuldeep Neote, Ph.D.
Senior director, New Ventures, J&J Innovation Center

4:20 - 6:30 p.m.
Networking reception

*Times and topics subject to change.


Robertson Life Sciences Building (RLSB)

2730 SW Moody Ave.
Portland, OR 97201
View in Google Maps





Driving Directions

From the Portland International Airport (PDX) to RLSB

  • Head northwest on NE Airport Way.
  • Use the right two lanes to turn slight right onto I-205 South.
  • Continue on I-205 South.
  • Take exit 21B to merge onto I-84 W/US-30 W toward Portland.
  • Use the left two lanes to take the exit towards Salem.
  • Merge onto I-5 South.
  • Take exit 299A to merge onto OR-43 S/SW Hood Ave toward Lake Oswego.
  • Turn left toward SW Macadam Ave.
  • Turn right onto SW Curry Street.
  • Turn left onto S.W. Moody Ave. RLSB will be on the right.

From RLSB to the Portland International Airport (PDX)

  • Head northwest on SW Moody Ave toward SW Meade Street.
  • Turn left onto SW River Pkwy.
  • Turn right onto SW Harbor Dr.
  • Use right two lanes to turn right onto SW Naito Pkwy/Pacific Hwy W.
  • Turn left to merge onto SE Morrison Bridge toward I-5 N/I-84 E.
  • Keep left at the fork to merge onto I-84 E.
  • Take exit 8 for I-205 N toward Seattle/Portland Airport.
  • Merge onto I-205 N.
  • Use right two lanes to take exit 24A for Airport Way W toward Portland Airport.
  • Continue on Airport Way to enter PDX International Airport.


Underground all-day visitor parking is available for $22. The entrance to the garage is at the intersection of SW Meade and Moody Ave. 

Onsite pay stations are also offered at the Schnitzer Lot, approximately one block north of the RLSB. Visitors can purchase daily parking permits for $11. Permits must be purchased same day or the day before. Purchase a parking permit online.


Public Transportation

Portland Streetcar

Portland’s streetcar stops at the corner of SW Moody and SW Meade, which is across the street and just south of the Robertson Life Sciences Building. Visitors may ride a TriMet bus downtown and transfer to the Portland streetcar. The closest streetcar stop to the downtown transit mall is at S.W. 5th and Market. The streetcar accommodates bikes and wheelchairs.

MAX and Bus

The South Waterfront/SW Moody Ave. Station on the MAX Orange Line is located right outside the Robertson Life Sciences Building. MAX Orange Line trains run every 15 minutes most of the day, and can accommodate bikes and wheelchairs. There are also a number of bus routes that serve the South Waterfront.


Food and beverage

Lunch, hors d'ouevres and refreshments will be provided for the 2019 Commercialization Conference. If attendees wish to purchase additional food and beverages, the following vendors hold on-site locations within the RLSB building.

Flying Elephant's Deli and Catering

Flying Elephant’s Deli is located at the Southeast half of the RLSB Ground Floor Atrium area and the adjoining outdoor seating patio area. Flying Elephant’s operates a coffee bar and a delicatessen offering breakfast, lunch and dinner, hot and cold beverages, meal specials and hot entries, baked goods, side salads and snacks, breads and accompaniments.


Featuring Starbucks Reserve-Clover Brewed coffee, oven-warmed food, free Wi-Fi, and mobile order and pay, the Starbucks at RLSB offers two convenient locations within the building. This locations can be found on the first floor, with a storefront in the South tower facing the new Tillicum bridge and a kiosk in the Atrium.

Portland attractions


Travel Portland

Travel Portland operates as a visitor information center, supports a climate of year-round hospitality, and helps the City of Portland, the state and region reap the rewards of a thriving visitor industry.

Eater PDX

Eater PDX is a guide to food and dining related news for Portland. Find highly rated food and spirits in the city, with restaurant opening and closure notifications.

Portland Monthly

Portland Monthly chronicles, challenges and celebrates one of America's most innovative cities, inspiring readers to explore the great city of Portland.


Platinum Sponsor

 GE Healthcare


Gold Sponsor 



Silver Sponsors 



 Schwabe logo



 Where Inc logo

Zidell logo 



Bronze Sponsors 



 Cresset logo



 Davis Wright Tremaine logo Deloitte logo

 Immix Law Group logo

 Keiretsu logo OCTRI logo



 Perkins Coie logo



 Union Bank logo 

White Summers logo




Contact , Alliance Manager, New Ventures, OHSU

Connect With Us